BIOMAT Database Logo BIOMAT Database Logo

Treatment of adult leukemia with L-asparaginase (NSC-109229). 1971

T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007565 Jaundice A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. Icterus,Jaundice, Hemolytic,Hemolytic Jaundice,Hemolytic Jaundices,Jaundices, Hemolytic
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C

Related Publications

T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
February 1970, Cancer chemotherapy reports,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia.
January 1977, Medical and pediatric oncology,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229).
June 1972, Cancer chemotherapy reports,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Phase I study of L-asparaginase (NSC 109229).
January 1975, Oncology,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229).
October 1972, Cancer chemotherapy reports,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Distribution and mechanism of clearance of L-asparaginase (NSC-109229).
December 1971, Cancer chemotherapy reports,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Induction and characteristics of resistance to L-asparaginase (NSC-109229) in mouse leukemia L5178Y.
April 1971, Cancer chemotherapy reports,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
October 1970, Cancer chemotherapy reports,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Failure of combination therapy with S-carbamyl-L-cysteine (SCC; NSC-102498) and L-asparaginase (NSC-109229) for L-asparaginase-resistant mouse lymphoma.
June 1972, Cancer chemotherapy reports,
T Onuma, and F Rosner, and R N Levy, and J Cuttner, and J H Moon, and R T Silver, and J Blom, and G Falkson, and R Burningham, and O Glidewell, and J F Holland
Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
October 1968, Cancer chemotherapy reports,
Copied contents to your clipboard!